Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06531824
PHASE3

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicines called angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). People who already take empagliflozin or any other sodium-glucose cotransporter-2 inhibitor (SGLT2i) can also join. The study is also open to people who currently do not take any of these treatments. The purpose of this study is to find out whether a medicine called BI 690517 helps people with chronic kidney disease when taken in combination with a study medicine called empagliflozin. Worsening of kidney function increases the risk for kidney failure, cardiovascular disease, and heart failure hospitalisation. After a run-in period, during which participants are confirmed to be receiving clinically appropriate renin-angiotensin system blockade and are established on empagliflozin, they are randomly assigned (by chance) to 1 of 2 groups. One group receives BI 690517 tablets, and the other group receives placebo tablets. Placebo tablets look like BI 690517 but do not contain any medicine. Participants take 1 study tablet once a day, in addition to empagliflozin, for the duration of the study. The doctors document when participants experience worsening of their kidney disease, go to hospital due to heart failure, or die of cardiovascular problems during the study. The time to these events is compared between the 2 treatment groups to see whether the treatment works. The study continues until the required number of events have occurred which is about 3 to 4 years. During this time, participants visit the study site about 5 times within the first 6 months. Then they visit the study site every 6 months. At the visits, doctors regularly check participants' health, take blood and urine samples, measure blood pressure and weight, check kidney function, and take note of any unwanted effects.

Official title: A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

8371

Start Date

2024-08-30

Completion Date

2026-12-31

Last Updated

2026-10-28

Healthy Volunteers

No

Interventions

DRUG

BI 690517

BI 690517 (called Type M randomized treatment)

DRUG

Placebo matching BI 690517

Placebo matching BI 690517

DRUG

Empagliflozin

Empagliflozin (called Type E)

Locations (562)

Apogee Clinical Research

Huntsville, Alabama, United States

Southwest Kidney Institute

Surprise, Arizona, United States

National Heart Institute

Beverly Hills, California, United States

Olive View - UCLA Medical Cente

Sylmar, California, United States

Interventional Cardiology Medical Group

West Hills, California, United States

South Denver Cardiology Associates

Littleton, Colorado, United States

Flourish Research

Boca Raton, Florida, United States

University of Florida Health Shands Hospital

Gainesville, Florida, United States

Florida Kidney Physicians LLC

Jacksonville Beach, Florida, United States

Total Research Group, LLC

Miami, Florida, United States

Bioresearch Partner

Miami, Florida, United States

Emory University School of Medicine

Atlanta, Georgia, United States

Joseph Maxwell Cleland Atlanta VA Medical Center

Decatur, Georgia, United States

East Coast Institute For Research LLC

Macon, Georgia, United States

Kootenai Research Services

Coeur d'Alene, Idaho, United States

Northwestern University

Chicago, Illinois, United States

University of Kansas Medical Center

Kansas City, Kansas, United States

Kansas Nephrology Research Institute, LLC

Wichita, Kansas, United States

University of Louisville

Louisville, Kentucky, United States

Medstar Health Research Institute

Baltimore, Maryland, United States

Lake Michigan Nephrology

Saint Joseph, Michigan, United States

St. Clair Nephrology Research, LLC

Shelby, Michigan, United States

Minneapolis VA Health Care System

Minneapolis, Minnesota, United States

Southwest Mississippi Nephrology, Pllc

Brookhaven, Mississippi, United States

Great Plains Nephrology

North Platte, Nebraska, United States

VA Southern Nevada Healthcare System

North Las Vegas, Nevada, United States

Sierra Nevada Specialty Care

Reno, Nevada, United States

Seacoast Kidney and Hypertension Specialists

Portsmouth, New Hampshire, United States

Advanced Heart Care, LLC

Bridgewater, New Jersey, United States

UNM Health Science Center

Albuquerque, New Mexico, United States

VA New York Harbor Healthcare System

New York, New York, United States

Metrolina Nephrology Associates, PA

Charlotte, North Carolina, United States

Metrolina Nephrology Associates, PA

Charlotte, North Carolina, United States

Carolina Kidney Associates

Greensboro, North Carolina, United States

Brookview Hills Research Associates LLC

Winston-Salem, North Carolina, United States

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

Northeast Endocrine Metabolic Associates

Philadelphia, Pennsylvania, United States

Temple University

Philadelphia, Pennsylvania, United States

Clinical Renal Associates

Upland, Pennsylvania, United States

Nephrology Associates, Inc

East Providence, Rhode Island, United States

University of Tennessee

Memphis, Tennessee, United States

Research Management, Inc - Austin

Austin, Texas, United States

Dallas Nephrology Associates Medical Clinic

DeSoto, Texas, United States

Academy Of Diabetes, Thyroid And Endocrine, PA

El Paso, Texas, United States

P&I Clinical Research, LLC

Lufkin, Texas, United States

Texas Institute for Kidney and Endocrine Disorders

Lufkin, Texas, United States

Renal Specialists of Houston, PA

Pasadena, Texas, United States

University Health

San Antonio, Texas, United States

University of Virginia Health System

Charlottesville, Virginia, United States

Kidney and Hypertension Specialists, PLLC

Manassas, Virginia, United States

Tidewater Physicians Multispecialty Group

Newport News, Virginia, United States

Salem VA Medical Center

Salem, Virginia, United States

Providence Medical Research Center

Spokane, Washington, United States

Fundacion INTECNUS

Bariloche, Argentina

Terapia Renal Domiciliaria

Buenos Aires, Argentina

Centro de Salud Renal Junin SRL

Buenos Aires, Argentina

Dres. Iribarren & Asoc. Consultario

Buenos Aires, Argentina

Glenny Corp - Centro Medico Saavedra

Buenos Aires, Argentina

CPSIC SRL - Cardiologia Palermo

CABA, Argentina

Sanatorio Pasteur S.A

Catamarca, Argentina

CEMIC

Ciudad Autonoma Buenos Aires, Argentina

CIMEL Chahin - Chahin S.A.

Lanús Este, Argentina

Centro Nefrologico del Mar

Mar del Plata, Argentina

Mains Bleues

Rafaela, Argentina

Hospital Privado de Rosario

Rosario, Argentina

Sanatorio Parque S.A.

Rosario, Argentina

Instituto de Nefrourologia y Nutricion de Salta

Salta, Argentina

Clinica El Castaño

San Juan, Argentina

Centro de Investigaciones Medicas Tucuman

San Miguel de Tucumán, Argentina

Centro Integral de Medicina Respiratoria - CIMER

San Miguel de Tucumán, Argentina

Instituto de Investigaciones Clinicas de Rosario

Santa Fe, Argentina

CEREHA S.A.- Centro de Estudios Renales e Hipertension Arterial

Villa Domínico, Argentina

Concord Hospital

Concord, New South Wales, Australia

Renal Research, Gosford

Gosford, New South Wales, Australia

Nepean Hospital

Kingswood, New South Wales, Australia

St George Hospital

Kogarah, New South Wales, Australia

Liverpool Hospital

Liverpool, New South Wales, Australia

Port Macquarie Base Hospital (PMBH)

Port Macquarie, New South Wales, Australia

Hervey Bay Hospital

Pialba, Queensland, Australia

AOVO Clinical Trials

Southport, Queensland, Australia

Griffith University

Southport, Queensland, Australia

Toowoomba Hospital

Toowoomba, Queensland, Australia

Flinders Medical Centre

Bedford Park, South Australia, Australia

Eastern Health-Box Hill Hospital

Box Hill, Victoria, Australia

Austin Health

Heidelberg Heights, Victoria, Australia

The Alfred Hospital

Melbourne, Victoria, Australia

St Vincent's Hospital Melbourne

Melbourne, Victoria, Australia

Sunshine Hospital

St Albans, Victoria, Australia

Macquarie University

New South Wales, Australia

Westmead Hospital

New South Wales, Australia

AZ Sint-Jan Brugge

Bruges, Belgium

Ziekenhuis Oost-Limburg

Genk, Belgium

UZ Brussel

Jette, Belgium

Centre Hospitalier Universitaire de Liège

Liège, Belgium

Centro de Pesquisa Clínica do Coração

Aracaju, Brazil

Santa Casa de Belo Horizonte

Belo Horizonte, Brazil

Centro de Pesquisa do Hospital Evangelico de Belo Horizonte

Belo Horizonte, Brazil

Universidade Estadual Paulista "Julio De Mesquita Filho"

Botucatu, Brazil

Hospital Universitário São Francisco na Providência de Deus

Bragança Paulista, Brazil

CEG - Centro de Endocrinologia Geloneze

Campinas, Brazil

And 462 more locations on ClinicalTrials.gov